SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001104659-20-011358
Filing Date
2020-02-05
Accepted
2020-02-05 17:21:29
Documents
2
Group Members
PETER KOLCHINSKYRAJEEV SHAH

Document Format Files

Seq Description Document Type Size
1 SC 13D tm206884d1_sc13d.htm SC 13D 73439
2 JOINT FILING AGREEMENT tm206884d1_ex99-1.htm EX-99.1 6369
  Complete submission text file 0001104659-20-011358.txt   81538
Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Filed by) CIK: 0001346824 (see all company filings)

IRS No.: 830406777 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 139 MAIN STREET CAMBRIDGE MA 02142
Business Address 139 MAIN STREET CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Subject) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-91312 | Film No.: 20579819
SIC: 2836 Biological Products, (No Diagnostic Substances)